Delivery Order SPE2DB25D3404-SPE2DB25FUNXU
- Not listed
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,128.74 for 200-unit vials of BOTOX on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,838.32 for 200-unit vials of BOTOX on May 27, 2025, with completion scheduled for June 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $85,479.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials, with an ultimate completion date of August 12, 2025. This is a non-set-aside competitive award issued as a child contract, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part...
- The Defense Logistics Agency awarded a $5,128.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with an ultimate completion date of August 4, 2025. This is a non-set-aside, competitively awarded delivery order with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, valued at $4,306.80, on June 18, 2025, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026,...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNXUDelivery Order
The Defense Logistics Agency awarded a $8,547.90 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on June 18, 2025, with an ultimate completion date of July 11, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for BOTOX vials reflects the company's ongoing role in supporting Defense Health Agency procurement and other government healthcare system needs through its flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 6/18/25 |